TY - JOUR
T1 - Wnt signalling suppresses voltage-dependent Na+ channel expression in postnatal rat cardiomyocytes
AU - Liang, Wenbin
AU - Cho, Hee Cheol
AU - Marbán, Eduardo
N1 - Funding Information:
The study was supported by the Cedars‐Sinai Board of Governors Heart Stem Cell Center (E.M.), Canadian Institutes of Health Research Fellowship (W.L.) and the American Heart Association (12SDG9020030 to H.C.C.) and NHLBI (1R01HL111646‐01A1 to H.C.C.).
Publisher Copyright:
© 2015 The Physiological Society.
PY - 2015/3/1
Y1 - 2015/3/1
N2 - Key points: Wnt signalling is activated in arrhythmogenic heart diseases, but its role in the regulation of cardiac ion channel expression is unknown. Exposure of neonatal rat ventricular myocytes to Wnt3a, an activator of canonical Wnt signalling, decreases Scn5a mRNA, Nav1.5 protein and Na+ current density. Wnt3a does not affect the inward rectifier K+ current or L-type Ca2+ channels. The Wnt pathway is a negative regulator of cardiac Na+ channel expression and may play a role in altered ion channel expression in heart disease. Wnt signalling plays crucial roles in heart development, but is normally suppressed postnatally. In arrhythmogenic conditions, such as cardiac hypertrophy and heart failure, Wnt signalling is reactivated. To explore the potential role of Wnt signalling in arrhythmogenic electrical remodelling, we examined voltage-dependent ion channels in cardiomyocytes. Treatment of neonatal rat ventricular myocytes with either recombinant Wnt3a protein or CHIR-99021 (CHIR, a glycogen synthase kinase-3β inhibitor) caused a dose-dependent increase in Wnt target gene expression (Axin2 and Lef1), indicating activation of the Wnt/β-catenin pathway. Cardiac Na+ current (INa) density was reduced by Wnt3a (-20 ± 4 vs. control -59 ± 7 pA pF-1, at -30 mV) or CHIR (-22 ± 5 pA pF-1), without changes in steady-state activation, inactivation or repriming kinetics. Wnt3a and CHIR also produced dose-dependent reductions in the mRNA level of Scn5a (the cardiac Na+ channel α subunit gene), as well as a 56% reduction (by Wnt3a) in the Nav1.5 protein level. Consistent with INa reduction, action potentials in Wnt3a-treated neonatal rat ventricular myocytes had a lower upstroke amplitude (91 ± 3 vs. control 137 ± 2 mV) and decreased maximum upstroke velocity (70 ± 10 vs. control 163 ± 15 V s-1). In contrast, inward rectifier K+ current and L-type Ca2+ channels were not affected by Wnt3a treatment. Taken together, our data indicate that the Wnt/β-catenin pathway suppresses INa in postnatal cardiomyocytes and may contribute to ion channel remodelling in heart disease.
AB - Key points: Wnt signalling is activated in arrhythmogenic heart diseases, but its role in the regulation of cardiac ion channel expression is unknown. Exposure of neonatal rat ventricular myocytes to Wnt3a, an activator of canonical Wnt signalling, decreases Scn5a mRNA, Nav1.5 protein and Na+ current density. Wnt3a does not affect the inward rectifier K+ current or L-type Ca2+ channels. The Wnt pathway is a negative regulator of cardiac Na+ channel expression and may play a role in altered ion channel expression in heart disease. Wnt signalling plays crucial roles in heart development, but is normally suppressed postnatally. In arrhythmogenic conditions, such as cardiac hypertrophy and heart failure, Wnt signalling is reactivated. To explore the potential role of Wnt signalling in arrhythmogenic electrical remodelling, we examined voltage-dependent ion channels in cardiomyocytes. Treatment of neonatal rat ventricular myocytes with either recombinant Wnt3a protein or CHIR-99021 (CHIR, a glycogen synthase kinase-3β inhibitor) caused a dose-dependent increase in Wnt target gene expression (Axin2 and Lef1), indicating activation of the Wnt/β-catenin pathway. Cardiac Na+ current (INa) density was reduced by Wnt3a (-20 ± 4 vs. control -59 ± 7 pA pF-1, at -30 mV) or CHIR (-22 ± 5 pA pF-1), without changes in steady-state activation, inactivation or repriming kinetics. Wnt3a and CHIR also produced dose-dependent reductions in the mRNA level of Scn5a (the cardiac Na+ channel α subunit gene), as well as a 56% reduction (by Wnt3a) in the Nav1.5 protein level. Consistent with INa reduction, action potentials in Wnt3a-treated neonatal rat ventricular myocytes had a lower upstroke amplitude (91 ± 3 vs. control 137 ± 2 mV) and decreased maximum upstroke velocity (70 ± 10 vs. control 163 ± 15 V s-1). In contrast, inward rectifier K+ current and L-type Ca2+ channels were not affected by Wnt3a treatment. Taken together, our data indicate that the Wnt/β-catenin pathway suppresses INa in postnatal cardiomyocytes and may contribute to ion channel remodelling in heart disease.
UR - http://www.scopus.com/inward/record.url?scp=84923396039&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84923396039&partnerID=8YFLogxK
U2 - 10.1113/jphysiol.2014.285551
DO - 10.1113/jphysiol.2014.285551
M3 - Article
C2 - 25545365
AN - SCOPUS:84923396039
SN - 0022-3751
VL - 593
SP - 1147
EP - 1157
JO - Journal of Physiology
JF - Journal of Physiology
IS - 5
ER -